Sponsor Pipeline

MingSight Pharmaceuticals, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06979076 A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or… CLL (Chronic Lymphocytic Leukemia) Not Yet Recruiting
Disease Areas
Leukemia (1) Chronic Lymphocytic Leukemia (CLL) (1)
Get alerts when MingSight Pharmaceuticals, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free